3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Unknown
1
Recruiting
1
Completed
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
NET
19
Gastrointestinal
19
Endocrine
19
Lymphoid
2
CNS
2
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Dermatologic
1
Breast
1
Conditions
Sarcoma
264
Osteosarcoma
80
Sarcoma, Ewing
50
Neoplasms
43
Melanoma
43
Gastrointestinal Stromal Tumors
41
Colorectal Neoplasms
39
Breast Neoplasms
37
Bone Neoplasms
36
Rhabdomyosarcoma
35
Neoplasm Metastasis
32
Ovarian Neoplasms
31
Neuroblastoma
30
Pancreatic Neoplasms
29
Stomach Neoplasms
27
Dendritic Cell Sarcoma, Interdigitating
27
Lung Neoplasms
26
Liposarcoma
26
Leiomyosarcoma
25
Glioblastoma
23
Uterine Cervical Neoplasms
22
Sarcoma, Synovial
22
Head and Neck Neoplasms
22
Carcinoma, Non-Small-Cell Lung
22
Esophageal Neoplasms
21
Sarcoma, Kaposi
18
Lymphoma
18
Carcinoma, Hepatocellular
18
Urinary Bladder Neoplasms
17
Prostatic Neoplasms
17
Interventions
amino-acid, glucose, and electrolyte solution
1
177Lu-octreotide, DOTA(0)-Tyr(3)-
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Gastro-enteropancreatic neuroendocrine tumor
×
Sarcoma
×
Clear all
NCT06441331
2026-05-01
KinLET
ITM Solucin GmbH
Phase 1
Recruiting
20 enrolled